<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976387</url>
  </required_header>
  <id_info>
    <org_study_id>52004443</org_study_id>
    <nct_id>NCT04976387</nct_id>
  </id_info>
  <brief_title>Post Operative Analgesia and Patient Satisfaction</brief_title>
  <official_title>Assessing Perceived Quality of Care With Differing Pain Management Protocols After Outpatient Otolaryngology Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To understand how patients perceive the quality of care they receive when given different&#xD;
      post-operative analgesic medications. Specifically the investigators want to assess whether&#xD;
      patients who receive non-opioid analgesia following surgery endorse appropriate quality and&#xD;
      satisfaction with their care compared to those who receive opioid medication.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is routine practice to give analgesic medication after any surgical procedure to provide&#xD;
      adequate pain control for patients. However with the increase in abuse of opioid prescription&#xD;
      medications, physicians have given a new emphasis to different pain regimens that aim to&#xD;
      limit the use of opioid medications. The investigator's previous clinical trial demonstrated&#xD;
      that for patients undergoing outpatient otolaryngology procedures, not only does Ibuprofen&#xD;
      provide equally effective analgesia compared to opioid medication but it can also decrease&#xD;
      overall opioid requirement.&#xD;
&#xD;
      In the current proposed study, the investigators wish to build on previous work. The&#xD;
      investigators hypothesize that with the addition of Acetaminophen to Ibuprofen, patients&#xD;
      undergoing outpatient otolaryngology procedures may not require opioid analgesia at all.&#xD;
      While numerous studies corroborate these results, there is little information about patients'&#xD;
      satisfaction with their care in light of a shifting emphasis on decreasing opioid&#xD;
      prescription. The primary goal of the current study is to better understand patients'&#xD;
      perception of care and level of satisfaction when given opioid versus non-opioid&#xD;
      postoperative analgesia. If there is conflicting data with regards to patients reporting&#xD;
      adequate pain control but poor satisfaction, then perhaps further public health intervention&#xD;
      may be necessary to provide additional patient education to help re-establish appropriate and&#xD;
      safe patient expectations for postsurgical analgesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to one of three groups prior to surgery. Patients will be prescribed Hydrocodone/acetaminophen, Ibuprofen, and/or Acetaminophen. Patients assigned to treatment Group 1 will take the opioid medication for initial pain control followed by Ibuprofen if pain is not adequately controlled. Group 2 patients will take Ibuprofen for initial pain control followed by the opioid medication if pain is not adequately controlled. Group 3 patients will take Ibuprofen for initial pain control followed by Acetaminophen if pain is not adequately controlled.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Researchers will not be blinded during the process of recruitment of patients due to necessity of prescribing specific medications. Researchers will be blinded during outcome assessment and data analysis.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient satisfaction with post operative pain control</measure>
    <time_frame>First clinic visit after surgery (7 days)</time_frame>
    <description>Patients will be surveyed if they were satisfied with their pain regimen and efficacy of pain control on a scale of 1-5. With 1 being very unsatisfied and 5 being very satisfied.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of analgesic regimen and patient attitudes toward treatment they received</measure>
    <time_frame>First clinic visit after surgery (7 days)</time_frame>
    <description>Patients attitude and overall experience with regards to their pain management will be assessed via the following questions:&#xD;
How many total days do you estimate that you required medication for your pain?&#xD;
If you were in a group that received hydrocodone, how many pills do you estimate that you took?&#xD;
If you were to have another surgery, would you ask your surgeon for a similar pain regimen?&#xD;
Was this surgery more painful than you anticipated?</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Patient Satisfaction</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Group 1: Hydrocodone/Acetaminophen and Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will take Hydrocodone/acetaminophen 5mg/325mg every 6 hours as needed for pain control&#xD;
If pain is not controlled after 60 minutes then can take Ibuprofen 600mg every 6 hours as needed for additional pain control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Ibuprofen and Hydrocodone/acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will take Ibuprofen 600mg every 6 hours as needed for pain control&#xD;
If pain is not controlled after 60 minutes then can take Hydrocodone/acetaminophen 5mg/325mg every 6 hours as needed for additional pain control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: Ibuprofen and Acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will take Ibuprofen 600mg every 6 hours as needed for pain control&#xD;
If pain is not controlled after 60 minutes then can take Acetaminophen 650mg every 6 hours as needed for additional pain control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocodone/Acetaminophen 5 Mg-325 Mg ORAL TABLET</intervention_name>
    <description>Patients are instructed to take Hydrocodone/acetaminophen 5 mg-325 mg oral tablets every 6 hours as needed for treatment of severe pain</description>
    <arm_group_label>Group 1: Hydrocodone/Acetaminophen and Ibuprofen</arm_group_label>
    <arm_group_label>Group 2: Ibuprofen and Hydrocodone/acetaminophen</arm_group_label>
    <other_name>Norco</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 600 mg</intervention_name>
    <description>Patients will take ibuprofen 600 mg every 6 hours as needed</description>
    <arm_group_label>Group 1: Hydrocodone/Acetaminophen and Ibuprofen</arm_group_label>
    <arm_group_label>Group 2: Ibuprofen and Hydrocodone/acetaminophen</arm_group_label>
    <arm_group_label>Group 3: Ibuprofen and Acetaminophen</arm_group_label>
    <other_name>Advil, Motrin, NSAID</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen 650 MG</intervention_name>
    <description>Patients will take Tylenol 650mg every 6 hours as needed</description>
    <arm_group_label>Group 3: Ibuprofen and Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between the ages of 18 and 89 years of age&#xD;
&#xD;
          -  Patients undergoing the following outpatient procedures at a LLUHS associated surgical&#xD;
             facility:&#xD;
&#xD;
               -  total or partial thyroidectomy&#xD;
&#xD;
               -  parathyroidectomy&#xD;
&#xD;
               -  parotidectomy&#xD;
&#xD;
               -  submandibular gland excision&#xD;
&#xD;
               -  neck mass excision&#xD;
&#xD;
               -  facial mass excision&#xD;
&#xD;
               -  MOHS defect repair&#xD;
&#xD;
               -  excision of cutaneous lesions&#xD;
&#xD;
               -  Other surgeries may qualify and will be assessed on a case by case basis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years old or older than 89 years old&#xD;
&#xD;
          -  Those allergic to Hydrocodone, Acetaminophen, or NSAIDS&#xD;
&#xD;
          -  Patients who are pregnant&#xD;
&#xD;
          -  Patients with chronic medical conditions including hepatic/renal disease that&#xD;
             precludes their ability to utilize the study medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khanh Nguyen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khanh Nguyen, M.D.</last_name>
    <phone>909-558-4000</phone>
    <phone_ext>88558</phone_ext>
    <email>KHANguyen@llu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jaibir S Pannu, M.D.</last_name>
    <phone>909-558-4000</phone>
    <phone_ext>88558</phone_ext>
    <email>jpannu@llu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda University Health System</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khanh Nguyen, M.D.</last_name>
      <phone>909-558-4000</phone>
      <phone_ext>88558</phone_ext>
      <email>KHANguyen@llu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jaibir S Pannu, M.D.</last_name>
      <phone>909-558-4000</phone>
      <phone_ext>88558</phone_ext>
      <email>jpannu@llu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wilson N, Kariisa M, Seth P, Smith H 4th, Davis NL. Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.</citation>
    <PMID>32191688</PMID>
  </reference>
  <reference>
    <citation>Olfson M, Rossen LM, Wall MM, Houry D, Blanco C. Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017. JAMA. 2019 Dec 17;322(23):2340-2342. doi: 10.1001/jama.2019.16566.</citation>
    <PMID>31846008</PMID>
  </reference>
  <reference>
    <citation>Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The Burden of Opioid-Related Mortality in the United States. JAMA Netw Open. 2018 Jun 1;1(2):e180217. doi: 10.1001/jamanetworkopen.2018.0217.</citation>
    <PMID>30646062</PMID>
  </reference>
  <reference>
    <citation>Pruitt LCC, Casazza GC, Newberry CI, Cardon R, Ramirez A, Krakovitz PR, Meier JD, Skarda DE. Opioid Prescribing and Use in Ambulatory Otolaryngology. Laryngoscope. 2020 Aug;130(8):1913-1921. doi: 10.1002/lary.28359. Epub 2019 Nov 27.</citation>
    <PMID>31774562</PMID>
  </reference>
  <reference>
    <citation>Dang S, Duffy A, Li JC, Gandee Z, Rana T, Gunville B, Zhan T, Curry J, Luginbuhl A, Cottrill E, Cognetti D. Postoperative opioid-prescribing practices in otolaryngology: A multiphasic study. Laryngoscope. 2020 Mar;130(3):659-665. doi: 10.1002/lary.28101. Epub 2019 Jun 21.</citation>
    <PMID>31225905</PMID>
  </reference>
  <reference>
    <citation>Foghsgaard S, Foghsgaard J, Homøe P. Early post-operative morbidity after superficial parotidectomy: a prospective study concerning pain and resumption of normal activity. Clin Otolaryngol. 2007 Feb;32(1):54-7.</citation>
    <PMID>17298314</PMID>
  </reference>
  <reference>
    <citation>Song CM, Ji YB, Bang HS, Kim KR, Kim H, Tae K. Postoperative Pain After Robotic Thyroidectomy by a Gasless Unilateral Axillo-Breast or Axillary Approach. Surg Laparosc Endosc Percutan Tech. 2015 Dec;25(6):478-82. doi: 10.1097/SLE.0000000000000204.</citation>
    <PMID>26422088</PMID>
  </reference>
  <reference>
    <citation>Ilyas AM, Miller AJ, Graham JG, Matzon JL. Pain Management After Carpal Tunnel Release Surgery: A Prospective Randomized Double-Blinded Trial Comparing Acetaminophen, Ibuprofen, and Oxycodone. J Hand Surg Am. 2018 Oct;43(10):913-919. doi: 10.1016/j.jhsa.2018.08.011.</citation>
    <PMID>30286851</PMID>
  </reference>
  <reference>
    <citation>Bartels K, Mayes LM, Dingmann C, Bullard KJ, Hopfer CJ, Binswanger IA. Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery. PLoS One. 2016 Jan 29;11(1):e0147972. doi: 10.1371/journal.pone.0147972. eCollection 2016.</citation>
    <PMID>26824844</PMID>
  </reference>
  <reference>
    <citation>Wu AW, Walgama ES, Genç E, Ting JY, Illing EA, Shipchandler TZ, Higgins TS. Multicenter study on the effect of nonsteroidal anti-inflammatory drugs on postoperative pain after endoscopic sinus and nasal surgery. Int Forum Allergy Rhinol. 2020 Apr;10(4):489-495. doi: 10.1002/alr.22506. Epub 2019 Dec 13.</citation>
    <PMID>31834679</PMID>
  </reference>
  <reference>
    <citation>Papoian V, Handy KG, Villano AM, Tolentino RA, Hassanein MT, Nosanov LS, Felger EA. Randomized control trial of opioid- versus nonopioid-based analgesia after thyroidectomy. Surgery. 2020 Jun;167(6):957-961. doi: 10.1016/j.surg.2020.01.011. Epub 2020 Feb 29.</citation>
    <PMID>32127178</PMID>
  </reference>
  <reference>
    <citation>Nguyen KK, Liu YF, Chang C, Park JJ, Kim CH, Hondorp B, Vuong C, Xu H, Crawley BK, Simental AA, Church CA, Inman JC. A Randomized Single-Blinded Trial of Ibuprofen- versus Opioid-Based Primary Analgesic Therapy in Outpatient Otolaryngology Surgery. Otolaryngol Head Neck Surg. 2019 May;160(5):839-846. doi: 10.1177/0194599819832528. Epub 2019 Mar 5.</citation>
    <PMID>30832548</PMID>
  </reference>
  <reference>
    <citation>Gostian AO, Loeser J, Tholen C, Wolber P, Otte M, Schwarz D, Heindl LM, Balk M, Gostian M. Postoperative pain after tonsillectomy - the value of standardized analgesic treatment protocols. Auris Nasus Larynx. 2020 Dec;47(6):1009-1017. doi: 10.1016/j.anl.2020.05.011. Epub 2020 Jun 12.</citation>
    <PMID>32536501</PMID>
  </reference>
  <reference>
    <citation>Hallway A, Vu J, Lee J, Palazzolo W, Waljee J, Brummett C, Englesbe M, Howard R. Patient Satisfaction and Pain Control Using an Opioid-Sparing Postoperative Pathway. J Am Coll Surg. 2019 Sep;229(3):316-322. doi: 10.1016/j.jamcollsurg.2019.04.020. Epub 2019 May 30.</citation>
    <PMID>31154092</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 15, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Khanh Nguyen</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Otolaryngology</keyword>
  <keyword>Head and Neck surgery</keyword>
  <keyword>Outpatient surgery</keyword>
  <keyword>Same day surgery</keyword>
  <keyword>Post operative pain</keyword>
  <keyword>Patient satisfaction</keyword>
  <keyword>Post operative analgesia</keyword>
  <keyword>NSAID</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Hydrocodone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share participants data after this study is finished with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

